To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MRPL42TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
459 supporting clones for gene MRPL42 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG495081 lung, mucoepidermoid carcinoma .a 1 to 696 8 to 702 exact tiling clone,   702/702
(100 %)
6 diff
(99.2 %id)
BG779780 adenocarcinoma, Prostate .b 33 to 759 62 to 799 G129Y K130H V131R S132C L133R ... tiling clone,   799/862
(92 %)
59 diff
(93.2 %id)
BG210543   .b 361 to 1165 1 to 802       802/802
(100 %)
58 diff
(92.8 %id)
BP432388   .b 643 to 982 1 to 340   tiling clone,   340/340
(100 %)
3 diff
(99.2 %id)
CB991936 placenta, pre-eclamptic placenta .c -11 to 763 28 to 818 P63X S64F V65C D66G I67H ...     791/824
(95 %)
29 diff
(96.5 %id)
CD693650 normal nasopharynx .c -10 to 545 28 to 587       560/587
(95 %)
19 diff
(96.8 %id)
BF674422 Prostate .c -10 to 646 1 to 650 C31V H32I K33N S34L T35R ...     650/848
(76 %)
30 diff
(96.5 %id)
BG400968 Kidney .c -10 to 607 1 to 627 T87H H88T D89*     627/932
(67 %)
15 diff
(98.4 %id)
BG942988 blood .c -9 to 562 1 to 572 exact     572/572
(100 %)
0 diff
(100 %id)
BG501621 embryonal carcinoma, testis .c -9 to 626 1 to 636 exact tiling clone,   636/636
(100 %)
0 diff
(100 %id)
BU927950 mixed (pool of 40 RNAs) .c -8 to 725 1 to 733 exact     733/735
(99 %)
7 diff
(99.1 %id)
CD520262 pooled .c -8 to 707 1 to 725 exact     725/822
(88 %)
16 diff
(98.1 %id)
CK001570 brain/CNS, Bulk tissue from Human Spinal cord .c -8 to 647 1 to 652 exact     652/655
(99 %)
15 diff
(97.8 %id)
DA620043   .c -8 to 568 2 to 578 exact capped   577/577
(100 %)
1 diff
(99.9 %id)
DA027708   .c 1 to 550 10 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA045941 bladder .c 1 to 560 10 to 569 exact capped   568/568
(100 %)
0 diff
(100 %id)
BG624059 placenta .c 1 to 617 9 to 625 exact     625/625
(100 %)
2 diff
(99.7 %id)
DA655637   .c 1 to 552 10 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA659210   .c 1 to 566 10 to 575 exact capped   574/574
(100 %)
1 diff
(99.9 %id)
DA738700   .c 1 to 555 10 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA750551   .c 1 to 570 10 to 579 exact capped   578/578
(100 %)
1 diff
(99.9 %id)
DA906448   .c 1 to 562 10 to 571 exact capped   570/570
(100 %)
1 diff
(99.9 %id)
BE018005 cervical carcinoma cell line, cervix .c 1 to 513 8 to 520       520/520
(100 %)
0 diff
(100 %id)
BF184003 bone marrow, from chronic myelogenous leukemia .c 1 to 693 8 to 693 C29V V30L C31S H32*     693/804
(86 %)
32 diff
(96.1 %id)
BF217768 brain, glioblastoma .c 1 to 748 8 to 745 C29V V30L C31S H32*     745/856
(87 %)
43 diff
(95.0 %id)
BF575311 muscle (skeletal) .c 1 to 554 8 to 558       558/920
(60 %)
12 diff
(98.7 %id)
BG399658 Kidney .c 1 to 536 8 to 547       547/834
(65 %)
7 diff
(99.2 %id)
BG503576 embryonal carcinoma, testis .c 1 to 642 8 to 653 E97D E98R V100S E101*     653/654
(99 %)
7 diff
(99.0 %id)
BG614310 embryonal carcinoma, testis .c 1 to 569 8 to 586 C31R N44*     586/899
(65 %)
17 diff
(98.2 %id)
CD700353 normal nasopharynx .c 1 to 596 27 to 621 exact     601/621
(96 %)
8 diff
(98.8 %id)
BF246804 brain, glioblastoma .c 1 to 630 7 to 653 L16C K17E H18T L19F F20I ...     651/740
(87 %)
47 diff
(93.7 %id)
BF210179 bone marrow, from chronic myelogenous leukemia .c 1 to 561 7 to 576 C29G C31V H32I K33N S34L ...     576/576
(100 %)
26 diff
(95.5 %id)
BF240369 bone marrow, from chronic myelogenous leukemia .c 1 to 613 7 to 610 C31G A50C L51S T52D S53F ...     612/823
(74 %)
26 diff
(96.9 %id)
BF575483 muscle (skeletal) .c 1 to 654 7 to 650 C31V H32I K33N S34L T35R ...     650/859
(75 %)
16 diff
(98.2 %id)
BG776164 lung, mucoepidermoid carcinoma .c 1 to 683 7 to 691 exact     691/691
(100 %)
8 diff
(98.9 %id)
DA261175 caudate nucleus .c 1 to 556 7 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
AV713742   .c 1 to 611 6 to 616 I15M T72A     616/616
(100 %)
5 diff
(99.2 %id)
DA753498   .c 1 to 466 7 to 472   capped   471/471
(100 %)
2 diff
(99.6 %id)
DA902434   .c 1 to 456 7 to 462   capped   461/461
(100 %)
1 diff
(99.8 %id)
DA359915 subthalamic nucleus .c 1 to 566 6 to 572 N135E L136S N137E P138S P139S ... capped   571/575
(99 %)
2 diff
(99.7 %id)
DA546882   .c 1 to 494 6 to 499   capped   498/498
(100 %)
1 diff
(99.8 %id)
BX404278 neuroblastoma .c 7 to 913 1 to 907 K17X N44X N46X N135X     907/907
(100 %)
0 diff
(100 %id)
BE619209 large cell carcinoma, lung .c 7 to 647 1 to 640 L51P     640/645
(99 %)
7 diff
(99.0 %id)
BE619758 large cell carcinoma, lung .c 7 to 607 602 to 1 L51P P74T I75Y R77S P78A ...     602/602
(100 %)
7 diff
(98.9 %id)
BI838363 pooled pancreas and spleen .c 7 to 734 1 to 723 L27Y Y28M V30C C31H H32K ...     723/723
(100 %)
8 diff
(98.9 %id)
TI_57163002   .c 7 to 734 32 to 754 L27Y Y28M V30C C31H H32K ...     723/754
(95 %)
14 diff
(98.2 %id)
BQ440292 eye, retinoblastoma .c 8 to 901 1 to 898 exact     898/900
(99 %)
15 diff
(98.4 %id)
BM802588 embryonal carcinoma, cell line, testis .c 10 to 802 1 to 796 exact     796/1107
(71 %)
24 diff
(97.9 %id)
BE566206 bladder, carcinoma, cell line .c 14 to 651 1 to 635 P78Q D79I P80L V81C H82I ...     633/856
(73 %)
17 diff
(98.1 %id)
BE567180 bladder, carcinoma, cell line .c 14 to 654 1 to 637 P78Q D79I P80L V81C H82I ...     637/871
(73 %)
13 diff
(98.6 %id)
BE565396 bladder, carcinoma, cell line .c 14 to 673 1 to 652 C29V V30L C31S H32*     652/811
(80 %)
28 diff
(96.6 %id)
CN362199 embryonic stem cells, cell lines H1, H7, andH9 .c 15 to 717 1 to 703 exact     703/703
(100 %)
3 diff
(99.6 %id)
BG389174 embryonal carcinoma, cell line, testis .c 16 to 742 27 to 758 K99N V100S E101*     732/1076
(68 %)
24 diff
(97.8 %id)
CN362197 embryonic stem cells, DMSO-treated H9 cellline .c 17 to 659 8 to 650 exact     643/650
(98 %)
0 diff
(100 %id)
BI227051 Burkitt lymphoma, lymph .c 17 to 652 1 to 640 E97A E98R K99N V100K E101L ...     640/876
(73 %)
10 diff
(98.9 %id)
CB159743 Liver .c 18 to 562 1 to 545 exact     545/545
(100 %)
0 diff
(100 %id)
BQ232944 melanotic melanoma, skin .c 19 to 851 1 to 843 exact     843/938
(89 %)
27 diff
(97.2 %id)
BE780941 eye, retinoblastoma .c 20 to 700 1 to 680 exact     680/680
(100 %)
9 diff
(98.7 %id)
BE871167 adenocarcinoma, colon .c 21 to 676 1 to 664 I67T P68S Y69I E70*     664/941
(70 %)
22 diff
(97.7 %id)
BM459573 leiomyosarcoma, uterus .c 23 to 900 1 to 890 exact     890/893
(99 %)
20 diff
(97.8 %id)
BQ921254 leiomyosarcoma, uterus .c 23 to 888 1 to 874 exact     874/916
(95 %)
16 diff
(98.3 %id)
CR601784 placenta .c 31 to 1782 1 to 1752 exact     1752/1752
(100 %)
0 diff
(100 %id)
AL540447 placenta .c 31 to 902 1 to 871 exact fully sequenced,   871/871
(100 %)
1 diff
(99.9 %id)
BC040240 Placenta, choriocarcinoma .c 32 to 1984 1 to 1953 exact tiling clone, available from MGC, AAA   1953/1953
(100 %)
0 diff
(100 %id)
DA028866   .c 33 to 559 51 to 578 A5C V6S W8M V9G M10D ... capped   577/577
(100 %)
1 diff
(99.9 %id)
CD385500 embryonic trophoblasts, made from WA01 stemcells .c 33 to 663 59 to 693 E104G     683/838
(81 %)
17 diff
(98.0 %id)
BJ990541 hepatoblastoma .c 33 to 579 54 to 600 exact     594/600
(99 %)
6 diff
(99.0 %id)
BG286890 bladder, transitional cell papilloma, cell line .c 33 to 647 51 to 666 exact     666/1121
(59 %)
12 diff
(99.0 %id)
CB991378 placenta, pre-eclamptic placenta .c 33 to 776 69 to 820 exact     804/827
(97 %)
23 diff
(97.3 %id)
NM_172177.2   .c 33 to 1993 62 to 2022 exact RefSeq,   2022/2022
(100 %)
0 diff
(100 %id)
TI_149295900   .c 33 to 665 807 to 181 exact     627/1006
(62 %)
8 diff
(99.3 %id)
BM455296 lymph, lymphoma, cell line .c 160 to 1175 1 to 1022   AAA   1022/1022
(100 %)
18 diff
(98.3 %id)
AL540446 placenta .c 1274 to 1778 507 to 4   fully sequenced,   767/770
(99 %)
15 diff
(98.1 %id)
BJ990542 hepatoblastoma .c 1279 to 1818 540 to 1       540/540
(100 %)
2 diff
(99.7 %id)
BE301513 cervical carcinoma cell line, cervix .c 1368 to 1789 423 to 1       423/423
(100 %)
10 diff
(97.7 %id)
BI254393 cervical carcinoma cell line, cervix .d 1 to 807 2 to 815 exact tiling clone,   815/815
(100 %)
18 diff
(97.8 %id)
AW179019 stomach .d 15 to 362 43 to 386       344/396
(86 %)
19 diff
(95.3 %id)
W25509 lung .d 16 to 431 1 to 418       418/418
(100 %)
3 diff
(99.3 %id)
BX102905 multiple sclerosis lesions .d 25 to 514 4 to 493       490/493
(99 %)
0 diff
(100 %id)
BI044465 ovary .d 31 to 323 121 to 413       293/421
(69 %)
7 diff
(98.4 %id)
CB265577 adipose .d 31 to 585 14 to 570 P139X tiling clone,   557/570
(97 %)
7 diff
(98.8 %id)
BF928688 nervous_tumor .d 34 to 407 13 to 386       374/387
(96 %)
7 diff
(98.2 %id)
BQ344838 nervous_tumor .d 34 to 407 13 to 386       374/387
(96 %)
7 diff
(98.2 %id)
BQ695064 adipose .d 34 to 509 124 to 598       475/599
(79 %)
9 diff
(98.5 %id)
BG120932 adenocarcinoma, cell line, Liver .d 35 to 585 62 to 623 A2C A4D A5C V6S K7T ... AAA   562/866
(64 %)
34 diff
(96.1 %id)
AA314339 colon .d 36 to 421 17 to 402       386/402
(96 %)
6 diff
(98.6 %id)
FN169255 breast carcinoma .e -10 to 66 4 to 81       78/83
(93 %)
8 diff
(90.4 %id)
FN149048 breast carcinoma .e -9 to 67 1 to 77   tiling clone,   77/77
(100 %)
3 diff
(96.2 %id)
BM193930 leukopheresis .e 1 to 173 8 to 180       180/190
(94 %)
8 diff
(95.8 %id)
AA345114 gall bladder .e 4 to 192 1 to 191       191/191
(100 %)
2 diff
(99.0 %id)
BM726733 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 13 to 314 1 to 302   fully sequenced,   302/302
(100 %)
0 diff
(100 %id)
FN086990 breast carcinoma .e 21 to 124 104 to 4     Submitted on the opposite strand 101/104
(97 %)
0 diff
(100 %id)
NM_172178.2   .e 33 to 2013 62 to 2042 exact RefSeq,   2042/2042
(100 %)
0 diff
(100 %id)
BU561400 testis .e 34 to 744 43 to 765 D141T R142D tiling clone,   723/869
(83 %)
27 diff
(96.9 %id)
CN362195 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 171 to 649 1 to 479       479/479
(100 %)
0 diff
(100 %id)
BM681517 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 253 to 736 502 to 19   fully sequenced, AAA   484/484
(100 %)
1 diff
(99.8 %id)
BE748867 bone marrow, from acute myelogenous leukemia .e 369 to 1119 755 to 1       755/1124
(67 %)
10 diff
(99.2 %id)
BM458743 lymph, lymphoma, cell line .e 369 to 1148 31 to 811       781/1156
(67 %)
25 diff
(97.9 %id)
BE856820 pooled .e 416 to 1147 740 to 7       734/740
(99 %)
9 diff
(98.8 %id)
BG028711 Bone, osteosarcoma, cell line .e 455 to 1207 1 to 753       753/900
(83 %)
26 diff
(97.2 %id)
BX329111 Placenta Cot 25-normalized .e 499 to 1253 755 to 1       755/755
(100 %)
2 diff
(99.8 %id)
CX787819 human embryonic stem cells .e 510 to 1379 1 to 869   tiling clone,   869/869
(100 %)
1 diff
(99.9 %id)
BQ019388 Chondrosarcoma, Left Pubic Bone .e 533 to 1145 631 to 19   AAA   613/626
(97 %)
3 diff
(99.6 %id)
BE778677 eye, retinoblastoma .e 596 to 1206 1 to 605       605/942
(64 %)
14 diff
(98.6 %id)
AW148667 brain, tumor, 5 pooled (see description) .e 623 to 1139 520 to 4       517/520
(99 %)
0 diff
(100 %id)
TI_149271820   .e 700 to 1143 560 to 117   AAA   444/935
(47 %)
0 diff
(100 %id)
BU674662 lung, Primary Lung Epithelial Cells .e 700 to 1143 462 to 19   AAA   444/452
(98 %)
0 diff
(100 %id)
BG427636 Kidney .e 715 to 1558 1 to 832       832/838
(99 %)
26 diff
(96.9 %id)
N89861 parathyroid gland, parathyroid tumor .e 733 to 1145 418 to 1       418/419
(99 %)
7 diff
(98.4 %id)
AA557195 breast .e 736 to 1218 487 to 5       483/487
(99 %)
0 diff
(100 %id)
BY997552   .e 742 to 1433 10 to 701       692/701
(98 %)
6 diff
(99.2 %id)
BE876971 large cell carcinoma, undifferentiated, lung .e 751 to 1492 1 to 740       740/744
(99 %)
8 diff
(99.0 %id)
AI191824 heart .e 763 to 1194 435 to 4       432/435
(99 %)
0 diff
(100 %id)
AI433166 lymph node, lymphoma, follicular mixed small and largecell .e 765 to 1195 465 to 35   AAA   431/431
(100 %)
0 diff
(100 %id)
AI719760 aorta .e 781 to 1262 1 to 481     Submitted on the opposite strand 481/481
(100 %)
2 diff
(99.6 %id)
AA453089   .e 783 to 1133 1 to 350       350/350
(100 %)
1 diff
(99.8 %id)
AA630656 lung, lung carcinoma .e 805 to 1187 383 to 1       383/383
(100 %)
0 diff
(100 %id)
CN362200 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 816 to 1253 1 to 437       437/676
(64 %)
3 diff
(99.6 %id)
BX348433 Placenta Cot 25-normalized .e 819 to 1253 1 to 436       436/436
(100 %)
5 diff
(98.9 %id)
CF141262 CNCAP(3)T-225 cell line, Prostate .e 827 to 1415 8 to 596       589/596
(98 %)
6 diff
(99.0 %id)
TI_154171928   .e 827 to 1483 85 to 749       665/990
(67 %)
14 diff
(98.6 %id)
CN362194 embryonic stem cells, cell lines H1, H7, andH9 .e 830 to 1510 1 to 682       682/682
(100 %)
3 diff
(99.6 %id)
AA300976 testis .e 832 to 1112 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
BM476710 leiomyosarcoma, uterus .e 859 to 1806 967 to 13     Submitted on the opposite strand 955/1094
(87 %)
0 diff
(100 %id)
AA639620 colon, colon tumor RER+ .e 903 to 1179 277 to 1       277/277
(100 %)
0 diff
(100 %id)
AA284393 germinal center B cell .e 952 to 1278 1 to 328       328/328
(100 %)
1 diff
(99.7 %id)
AW675033 cervix .e 952 to 1365 22 to 435       414/435
(95 %)
6 diff
(98.7 %id)
BG610757 adenocarcinoma, Prostate .e 1014 to 1728 1 to 712       712/712
(100 %)
7 diff
(99.1 %id)
BF094365 uterus_tumor .e 1055 to 1350 1 to 298       298/307
(97 %)
6 diff
(98.1 %id)
BG779106 adenocarcinoma, Prostate .e 1066 to 1667 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BG771391 adenocarcinoma, Prostate .e 1066 to 1819 1 to 759       759/759
(100 %)
14 diff
(98.2 %id)
BF831621 head_neck .e 1067 to 1322 257 to 1     Submitted on the opposite strand 257/257
(100 %)
3 diff
(98.9 %id)
DA727397   .e 1081 to 1850 2 to 778   capped   777/780
(99 %)
17 diff
(97.9 %id)
FN061207 breast carcinoma .e 1104 to 1195 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
TI_149291744   .e 1137 to 1857 787 to 65   tiling clone, AAA   723/725
(99 %)
9 diff
(98.8 %id)
FN096064 breast carcinoma .e 1151 to 1228 1 to 77       77/78
(98 %)
3 diff
(96.2 %id)
W33141 parathyroid gland, parathyroid tumor .e 1169 to 1481 1 to 320       320/320
(100 %)
10 diff
(96.9 %id)
BF185418 bone marrow, from acute myelogenous leukemia .e 1174 to 1721 1 to 553       553/639
(86 %)
27 diff
(95.8 %id)
BF242248 bone marrow, from acute myelogenous leukemia .e 1176 to 1898 1 to 712   tiling clone,   712/872
(81 %)
23 diff
(97.4 %id)
BF095154 uterus_tumor .e 1181 to 1335 1 to 154       154/154
(100 %)
8 diff
(94.9 %id)
AW886987 ovary .e 1202 to 1367 8 to 174       167/174
(95 %)
6 diff
(96.6 %id)
FN065925 breast carcinoma .e 1232 to 1350 122 to 1     Submitted on the opposite strand 122/125
(97 %)
5 diff
(96.0 %id)
BG291708 bladder, transitional cell papilloma, cell line .e 1246 to 1990 8 to 760   tiling clone,   753/936
(80 %)
49 diff
(94.8 %id)
CB160814 Liver .e 1253 to 1837 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BF131734 hypernephroma, Kidney .e 1262 to 1727 1 to 468       468/468
(100 %)
8 diff
(98.3 %id)
ES316161 pool of melanoma cell lines .e 1270 to 1754 522 to 38     Submitted on the opposite strand 485/522
(92 %)
0 diff
(100 %id)
BU675596 lung, Primary Lung Epithelial Cells .e 1287 to 1857 586 to 19   AAA   568/568
(100 %)
5 diff
(99.2 %id)
CN276294 embryonic stem cells, DMSO-treated H9 cellline .e 1298 to 1814 1 to 517   AAA   517/517
(100 %)
0 diff
(100 %id)
DB487070 hypothalamus .e 1323 to 1769 1 to 447       447/447
(100 %)
0 diff
(100 %id)
BU682163 lung .e 1327 to 1857 549 to 19   AAA   531/531
(100 %)
0 diff
(100 %id)
DB544228 hippocampus .e 1343 to 1814 1 to 472     Submitted on the opposite strand 472/472
(100 %)
2 diff
(99.6 %id)
AI476335 pooled .e 1366 to 1807 442 to 1       442/442
(100 %)
4 diff
(99.1 %id)
AI332939 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1372 to 1861 494 to 5   tiling clone,   490/494
(99 %)
0 diff
(100 %id)
BE874849 large cell carcinoma, undifferentiated, lung .e 1374 to 1814 1 to 441       441/441
(100 %)
0 diff
(100 %id)
AA452920   .e 1417 to 1811 394 to 3       392/394
(99 %)
0 diff
(100 %id)
AW674302 cervix .e 1424 to 1814 401 to 11   AAA   391/391
(100 %)
0 diff
(100 %id)
AI698717 pooled .e 1484 to 1859 391 to 17   AAA   375/375
(100 %)
5 diff
(98.7 %id)
AI375985   .e 1497 to 1861 368 to 4       365/368
(99 %)
0 diff
(100 %id)
BM781971 myeloma .e 1513 to 1827 1 to 315       315/315
(100 %)
5 diff
(98.5 %id)
FN062586 breast carcinoma .e 1525 to 1611 87 to 1     Submitted on the opposite strand 87/87
(100 %)
0 diff
(100 %id)
DV460981 cochlea, ear .e 1534 to 1734 1 to 202       202/202
(100 %)
9 diff
(95.6 %id)
FN164556 breast carcinoma .e 1563 to 1656 99 to 1     Submitted on the opposite strand 99/99
(100 %)
3 diff
(97.0 %id)
AA830886 germinal center B cell .e 1574 to 1859 300 to 15   AAA   286/286
(100 %)
0 diff
(100 %id)
FN141344 breast carcinoma .e 1581 to 1686 1 to 105       105/105
(100 %)
3 diff
(97.2 %id)
FN108608 breast carcinoma .e 1650 to 1754 105 to 1     Submitted on the opposite strand 105/105
(100 %)
0 diff
(100 %id)
FN089280 breast carcinoma .e 1658 to 1772 112 to 1     Submitted on the opposite strand 112/112
(100 %)
2 diff
(98.3 %id)
FN071019 breast carcinoma .e 1662 to 1732 69 to 1     Submitted on the opposite strand 69/70
(98 %)
2 diff
(97.2 %id)
BG402503 Kidney .f -11 to 649 1 to 673 P78Q D79I P80L V81C H82I ...     673/793
(84 %)
15 diff
(98.2 %id)
CB962713 Blood vessels - aorta, basilar and artery .f -11 to 726 1 to 744 exact     744/761
(97 %)
8 diff
(99.0 %id)
CB998953 Pooled-Skin .f -11 to 753 1 to 770 exact     770/841
(91 %)
22 diff
(97.4 %id)
CB986718 Pooled-Glandular .f -11 to 586 1 to 605 V81E W123L Y124V P125S H126L ...     605/788
(76 %)
11 diff
(98.7 %id)
CB958853 Pooled-Glandular .f -11 to 730 1 to 749 exact     749/754
(99 %)
12 diff
(98.5 %id)
CD689509 normal nasopharynx .f -10 to 403 15 to 430       416/430
(96 %)
14 diff
(96.8 %id)
CD704982 normal nasopharynx .f -10 to 639 31 to 680 exact     650/680
(95 %)
6 diff
(99.2 %id)
BF677882 Prostate .f -10 to 603 1 to 619 C31G L49A A50C L51S T52D ...     566/663
(85 %)
29 diff
(95.7 %id)
BG573917 placenta .f -10 to 747 1 to 760 exact     760/844
(90 %)
8 diff
(99.1 %id)
BG707088 brain, hypothalamus .f -10 to 732 1 to 748 K99T V100S E101*     748/749
(99 %)
17 diff
(97.8 %id)
BG707001 brain, hypothalamus .f -10 to 622 1 to 653 K7T W8M V9G M10*     653/1000
(65 %)
28 diff
(97.2 %id)
BI668258 brain, hypothalamus .f -10 to 732 1 to 751 K99Q V100S E101*     751/751
(100 %)
17 diff
(97.8 %id)
BU959064 mixed (pool of 40 RNAs) .f -10 to 579 1 to 592 K93X G106R K114Q H130P R133P AAA   592/592
(100 %)
12 diff
(98.0 %id)
AL136659 brain .f -9 to 1834 1 to 1844 exact tiling clone, available from DKFZ, AAA   1844/1844
(100 %)
0 diff
(100 %id)
FN175222 breast carcinoma .f -9 to 71 1 to 81       81/81
(100 %)
5 diff
(93.9 %id)
BG429393 Kidney .f -9 to 647 1 to 667 P74L I75S P76L R77X P78Q ...     666/709
(93 %)
19 diff
(97.4 %id)
AK000285   .f -8 to 1989 1 to 2000 exact available from FLJ, AAA   2000/2000
(100 %)
11 diff
(99.5 %id)
DA021923   .f -8 to 540 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA040043 bladder .f -8 to 558 2 to 568 exact capped   567/567
(100 %)
0 diff
(100 %id)
AV715818   .f -8 to 419 1 to 428       428/428
(100 %)
6 diff
(98.6 %id)
DB475405 hippocampus .f -8 to 466 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
BG259734 embryonal carcinoma, cell line, testis .f -8 to 719 1 to 720 exact     720/944
(76 %)
15 diff
(98.5 %id)
BQ435640 testis .f -8 to 740 1 to 752 exact     752/752
(100 %)
6 diff
(99.3 %id)
CD110402 Blood vessels - aorta, basilar and artery .f -8 to 740 1 to 753 K140X     753/754
(99 %)
14 diff
(98.2 %id)
CD511238 Blood vessels - aorta, basilar and artery .f -8 to 760 1 to 775 exact     775/786
(98 %)
12 diff
(98.5 %id)
DA023552   .f 1 to 560 10 to 569 exact capped   568/568
(100 %)
0 diff
(100 %id)
DA163721 amygdala .f 1 to 560 10 to 569 exact capped   568/568
(100 %)
0 diff
(100 %id)
DA303194 hippocampus .f 1 to 582 10 to 591 exact capped   590/590
(100 %)
1 diff
(99.9 %id)
DA429912 colon .f 1 to 559 10 to 568 exact capped   567/567
(100 %)
0 diff
(100 %id)
DA481518   .f 1 to 533 10 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BQ233419 leiomyosarcoma, uterus .f 1 to 925 9 to 944 exact AAA   944/990
(95 %)
31 diff
(96.9 %id)
CD357326 Blood vessels - aorta, basilar and artery .f 1 to 698 9 to 719 I75Y R77S P78A D79R P80S ...     719/847
(84 %)
34 diff
(96.0 %id)
DA659667   .f 1 to 491 10 to 501   capped   500/502
(99 %)
3 diff
(99.5 %id)
DA823477 pericardium .f 1 to 559 10 to 568 exact capped   567/567
(100 %)
0 diff
(100 %id)
DA832864 placenta .f 1 to 589 10 to 598 exact capped   597/608
(98 %)
2 diff
(99.7 %id)
DA888261   .f 1 to 522 10 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DB164711 thymus .f 1 to 563 10 to 572 exact capped   571/571
(100 %)
0 diff
(100 %id)
DB196871 trachea .f 1 to 575 10 to 584 I75M capped   583/583
(100 %)
2 diff
(99.7 %id)
AF151038 umbilical cord blood .f 1 to 1990 8 to 2003 N135E L136S N137*     2003/2010
(99 %)
28 diff
(98.7 %id)
BG941337 blood .f 1 to 287 8 to 294       294/294
(100 %)
2 diff
(99.4 %id)
BG944890 blood .f 1 to 521 8 to 528       528/528
(100 %)
1 diff
(99.9 %id)
BF382336 brain, primitive neuroectoderm .f 1 to 682 8 to 676 C29G C31V H32I K33N S34L ...     676/823
(82 %)
28 diff
(96.6 %id)
BF791012 muscle (skeletal) .f 1 to 665 8 to 662 C29V V30L C31S H32*     662/866
(76 %)
28 diff
(96.8 %id)
BG493887 lung, mucoepidermoid carcinoma .f 1 to 345 8 to 352       352/496
(70 %)
1 diff
(99.8 %id)
BG530977 embryonal carcinoma, testis .f 1 to 647 8 to 661 K134Q N135E L136S N137E P138S ...     661/757
(87 %)
11 diff
(98.6 %id)
BM193440 leukopheresis .f 1 to 488 8 to 495       495/495
(100 %)
6 diff
(98.8 %id)
BE245156 leukopheresis .f 1 to 510 8 to 517       517/517
(100 %)
7 diff
(98.7 %id)
AV682498 hepatocellular carcinoma .f 1 to 695 7 to 701 exact     701/701
(100 %)
11 diff
(98.5 %id)
DB466878 hippocampus .f 1 to 428 7 to 433       433/434
(99 %)
8 diff
(98.2 %id)
DB484637 hypothalamus .f 1 to 345 7 to 350       350/357
(98 %)
5 diff
(98.6 %id)
DA550316   .f 1 to 527 27 to 553   capped   533/533
(100 %)
0 diff
(100 %id)
BF676933 Prostate .f 1 to 652 7 to 661 K12N R13E T14N I15Y K17E ...     661/898
(73 %)
41 diff
(95.5 %id)
BF665616 brain, primitive neuroectoderm .f 1 to 708 7 to 705 P138S P139S D141R R142Q     705/799
(88 %)
18 diff
(97.8 %id)
BG492616 lung, mucoepidermoid carcinoma .f 1 to 732 7 to 740 exact     740/740
(100 %)
19 diff
(97.5 %id)
CB962780 Blood vessels - aorta, basilar and artery .f 1 to 592 7 to 601 E98K K114Q R142K     601/760
(79 %)
12 diff
(98.5 %id)
DA906834   .f 1 to 564 8 to 571 T14I capped   570/570
(100 %)
2 diff
(99.7 %id)
DA906875   .f 1 to 563 8 to 571 A2P T14I capped   570/570
(100 %)
3 diff
(99.5 %id)
DA021573   .f 1 to 573 7 to 579 exact capped   578/578
(100 %)
0 diff
(100 %id)
DA141123 alzheimer cortex .f 1 to 554 7 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA161446 amygdala .f 1 to 563 7 to 569 exact capped   568/568
(100 %)
1 diff
(99.9 %id)
DA426107 colon .f 1 to 559 7 to 566 Y61C capped   565/565
(100 %)
2 diff
(99.7 %id)
DA482790   .f 1 to 582 7 to 589 R122P W123L Y124V P125S H126S ... capped   588/588
(100 %)
2 diff
(99.7 %id)
DA534984 heart .f 1 to 555 7 to 562 A5C V6S W8M V9G M10D ... capped   561/561
(100 %)
1 diff
(99.9 %id)
DA648214   .f 1 to 517 7 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
DA735529   .f 1 to 799 7 to 804 exact capped   803/803
(100 %)
4 diff
(99.6 %id)
DA818582   .f 1 to 559 7 to 565 exact capped   564/564
(100 %)
0 diff
(100 %id)
DA902268   .f 1 to 566 7 to 572 exact capped   571/571
(100 %)
0 diff
(100 %id)
DA904328   .f 1 to 562 7 to 568 exact capped   567/567
(100 %)
0 diff
(100 %id)
DB183021 liver, tumor tissue .f 1 to 551 7 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB187911 liver, tumor tissue .f 1 to 374 7 to 380   capped   379/379
(100 %)
0 diff
(100 %id)
DB245611 uterus, tumor tissue .f 1 to 260 7 to 266   capped   265/265
(100 %)
6 diff
(97.8 %id)
TI_44346224   .f 1 to 732 98 to 837 K99Q V100S E101*     744/837
(88 %)
18 diff
(97.9 %id)
DA902500   .f 1 to 463 5 to 467   capped   466/466
(100 %)
1 diff
(99.8 %id)
BM464431 leiomyosarcoma, uterus .f 1 to 938 27 to 971 exact     947/1090
(86 %)
26 diff
(97.7 %id)
DB135554 thymus .f 1 to 553 4 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA759866   .f 1 to 541 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
AW179011 stomach .f 2 to 357 23 to 382       357/394
(90 %)
7 diff
(98.3 %id)
DR002159 fetal brain .f 3 to 551 1 to 549       549/549
(100 %)
4 diff
(99.3 %id)
CD652866 Embryonic Stem cells .f 6 to 752 12 to 752 exact     741/809
(91 %)
15 diff
(98.2 %id)
BU182626 melanotic melanoma, skin .f 7 to 702 1 to 700 exact AAA   700/883
(79 %)
6 diff
(99.4 %id)
BG118754 adenocarcinoma, cell line, Liver .f 8 to 707 1 to 700 C31V H32I K33N S34L T35R ...     700/976
(71 %)
16 diff
(98.4 %id)
BX334397 Placenta Cot 25-normalized .f 9 to 1109 1 to 1089 exact     1089/1106
(98 %)
26 diff
(97.7 %id)
BG391928 embryonal carcinoma, cell line, testis .f 9 to 819 1 to 810 exact     810/957
(84 %)
25 diff
(97.4 %id)
BG340360 leiomyosarcoma cell line, uterus .f 9 to 738 1 to 729 exact     729/961
(75 %)
14 diff
(98.6 %id)
BU948408 insulinoma, Pancreas .f 10 to 608 1 to 599 exact     599/599
(100 %)
3 diff
(99.5 %id)
CB134653 Liver .f 10 to 536 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BE568514 bladder, carcinoma, cell line .f 11 to 600 1 to 583 C29V V30L C31S H32*     583/874
(66 %)
6 diff
(99.4 %id)
DR157065 human embryonic stem cells differentiated toan early endodermal cell type .f 11 to 779 1 to 769 exact     769/769
(100 %)
0 diff
(100 %id)
CN362201 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 13 to 651 1 to 639 exact     639/639
(100 %)
1 diff
(99.9 %id)
BE748275 bone marrow, from acute myelogenous leukemia .f 14 to 694 1 to 681 P74L I75S P76L R77G P78Q ...     681/890
(76 %)
14 diff
(98.5 %id)
BG178950 adenocarcinoma, cell line, Prostate .f 15 to 811 1 to 794 exact     794/860
(92 %)
25 diff
(97.1 %id)
BM923171 leukocyte .f 15 to 979 9 to 984 W123C K140X     976/1093
(89 %)
37 diff
(96.7 %id)
CF272315 Brain glioblastoma .f 15 to 881 1 to 871 exact     871/899
(96 %)
11 diff
(98.8 %id)
AJ715249 bone marrow .f 17 to 478 19 to 479       461/479
(96 %)
6 diff
(98.8 %id)
CN362196 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 17 to 751 1 to 735 exact     735/735
(100 %)
1 diff
(99.9 %id)
CB162989 Liver .f 17 to 644 1 to 627 exact     627/627
(100 %)
1 diff
(99.9 %id)
CD625148   .f 18 to 576 1 to 559 exact     559/566
(98 %)
5 diff
(99.2 %id)
CD625149   .f 18 to 576 563 to 5 exact     559/563
(99 %)
1 diff
(99.9 %id)
BF971175 adrenal cortex carcinoma, cell line, adrenal gland .f 18 to 735 1 to 713 exact     713/742
(96 %)
18 diff
(97.6 %id)
BM479310 eye, retinoblastoma .f 18 to 987 1 to 986 exact     986/1042
(94 %)
24 diff
(97.7 %id)
BM466017 embryonal carcinoma, cell line, testis .f 18 to 878 1 to 877 exact     877/985
(89 %)
23 diff
(97.7 %id)
DR158132 human embryonic stem cells differentiated toan early endodermal cell type .f 18 to 783 1 to 766 exact     766/766
(100 %)
1 diff
(99.9 %id)
BM804278 duodenal adenocarcinoma, cell line, small intestine .f 19 to 882 1 to 871 exact     871/1115
(78 %)
33 diff
(97.1 %id)
BQ421618 embryonal carcinoma, cell line, testis .f 19 to 898 1 to 888 exact     888/888
(100 %)
13 diff
(98.6 %id)
CB148122 Liver .f 19 to 674 1 to 656 exact     656/656
(100 %)
0 diff
(100 %id)
DR000136 fetal brain .f 19 to 744 8 to 733 exact     726/740
(98 %)
1 diff
(99.9 %id)
AA336674 endometrium .f 22 to 436 1 to 415       415/415
(100 %)
9 diff
(97.9 %id)
AA337956 endometrium .f 22 to 266 1 to 245       245/245
(100 %)
0 diff
(100 %id)
AW954843   .f 23 to 512 1 to 490       490/617
(79 %)
7 diff
(98.9 %id)
TI_154192049   .f 24 to 660 50 to 688 K140X     639/1014
(63 %)
7 diff
(99.4 %id)
CF130118 Chondrosarcoma Lung Metastasis cell lines, lung .f 25 to 642 1 to 618 K140X     618/618
(100 %)
0 diff
(100 %id)
AV752555 Pituitary .f 25 to 689 1 to 651 exact     651/752
(86 %)
9 diff
(98.9 %id)
BE782148 eye, retinoblastoma .f 26 to 737 1 to 713 P78Q D79I P80L V81C H82I ...     713/966
(73 %)
16 diff
(98.4 %id)
BE888036 leiomyosarcoma, uterus .f 27 to 763 1 to 738 exact     738/871
(84 %)
26 diff
(97.1 %id)
BI335553 cervical carcinoma cell line, cervix .f 28 to 651 45 to 667 L96W     623/667
(93 %)
7 diff
(99.0 %id)
AV703946 adrenal gland .f 31 to 542 9 to 520       512/523
(97 %)
7 diff
(98.7 %id)
CR614600 neuroblastoma .f 31 to 1945 1 to 1915 exact     1915/1915
(100 %)
0 diff
(100 %id)
AL517367 brain, neuroblastoma, neuroblastoma cells .f 31 to 1005 1 to 974 N44X N46X Y61X N135X fully sequenced,   974/974
(100 %)
2 diff
(99.8 %id)
BX399860 Placenta Cot 25-normalized .f 31 to 935 1 to 905 Y61X     905/905
(100 %)
1 diff
(99.9 %id)
DN990575 brain, whole brain .f 31 to 718 45 to 733 N44K C45L N46Q V47R E48R ...     689/733
(93 %)
9 diff
(98.8 %id)
BE535234 cervix .f 32 to 686 1 to 652 C31V H32I K33N S34L T35R ...     652/972
(67 %)
13 diff
(98.7 %id)
AF078860 pituitary tumor .f 33 to 1123 48 to 1137 exact AAA   1137/1137
(100 %)
7 diff
(99.4 %id)
AF135160   .f 33 to 721 52 to 740 exact AAA   740/740
(100 %)
1 diff
(99.9 %id)
DA024461   .f 33 to 559 57 to 583 exact capped   582/582
(100 %)
0 diff
(100 %id)
AW390412 stomach .f 33 to 548 1 to 516       516/516
(100 %)
16 diff
(96.9 %id)
DW410551 Liver .f 33 to 306 59 to 333       324/333
(97 %)
13 diff
(96.1 %id)
DA549804   .f 33 to 557 56 to 580 exact capped   579/579
(100 %)
0 diff
(100 %id)
BE560944 Burkitt lymphoma, lymph .f 33 to 763 1 to 723 C31W H32S K33*     723/933
(77 %)
26 diff
(97.3 %id)
BM801560 duodenal adenocarcinoma, cell line, small intestine .f 33 to 853 85 to 905 exact     875/905
(96 %)
10 diff
(98.9 %id)
BQ278337 mixed (pool of 40 RNAs) .f 33 to 421 71 to 460       460/1497
(30 %)
9 diff
(99.4 %id)
NM_014050.2   .f 33 to 1989 62 to 2018 exact RefSeq, AAA   2018/2018
(100 %)
0 diff
(100 %id)
BM147739 leukopheresis .f 33 to 479 67 to 513       513/513
(100 %)
2 diff
(99.7 %id)
BM149004 leukopheresis .f 33 to 196 70 to 231       228/246
(92 %)
15 diff
(94.0 %id)
CN362192 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 34 to 656 1 to 623 exact     623/623
(100 %)
0 diff
(100 %id)
BM129628 Islets of Langerhans, Pancreas .f 34 to 548 1 to 515       515/519
(99 %)
2 diff
(99.7 %id)
FN110434 breast carcinoma .f 35 to 117 81 to 1     Submitted on the opposite strand 81/96
(84 %)
3 diff
(96.9 %id)
N46796 multiple sclerosis lesions .f 37 to 376 1 to 340   fully sequenced,   340/340
(100 %)
2 diff
(99.5 %id)
AA314286 colon .f 39 to 513 1 to 475       475/484
(98 %)
1 diff
(99.8 %id)
AA316235 colon .f 39 to 418 1 to 381       381/381
(100 %)
1 diff
(99.8 %id)
BF754841 colon .f 39 to 343 1 to 303       303/306
(99 %)
6 diff
(98.1 %id)
BE535633 cervix .f 39 to 802 1 to 759 C31V H32I K33N S34L T35R ...     759/760
(99 %)
15 diff
(98.1 %id)
BE888829 leiomyosarcoma, uterus .f 39 to 651 1 to 615 exact     615/1092
(56 %)
7 diff
(99.4 %id)
CN362198 embryonic stem cells, DMSO-treated H9 cellline .f 42 to 583 1 to 543 M115N F116V F117L T118Y T119Y ...     543/543
(100 %)
1 diff
(99.9 %id)
N57134 placenta .f 48 to 432 1 to 386   fully sequenced,   386/386
(100 %)
0 diff
(100 %id)
BE895820 melanotic melanoma, skin .f 51 to 675 1 to 635 exact     635/783
(81 %)
19 diff
(97.6 %id)
AV753822 pituitary tumor .f 60 to 418 1 to 355       355/359
(98 %)
8 diff
(97.8 %id)
N46483.
matches multiple genes
melanocyte .f 108 to 371 1 to 264     also hits gene EXTL3 264/271
(97 %)
3 diff
(98.9 %id)
BF184653 bone marrow, from chronic myelogenous leukemia .f 108 to 884 1 to 779 C29R C31V H32I K33N S34L ...     779/818
(95 %)
48 diff
(94.2 %id)
TI_154125132   .f 113 to 661 631 to 82 N24K G25W A26S L27F Y28I ... AAA   550/977
(56 %)
1 diff
(99.9 %id)
CA416061 Chondrosarcoma Cell line .f 113 to 661 563 to 14 N24K G25W A26S L27F Y28I ... AAA   550/650
(84 %)
1 diff
(99.9 %id)
CR533495   .f 127 to 570 1 to 444 exact     444/444
(100 %)
0 diff
(100 %id)
CV024887 mixed .f 127 to 554 1 to 429       429/548
(78 %)
7 diff
(98.8 %id)
TI_1948097938   .f 128 to 554 132 to 557       426/694
(61 %)
9 diff
(98.8 %id)
TI_1948098095   .f 128 to 552 131 to 555       425/726
(58 %)
8 diff
(98.9 %id)
TI_1948098266   .f 128 to 554 129 to 555       427/739
(57 %)
7 diff
(99.1 %id)
FN154850 breast carcinoma .f 134 to 236 101 to 1     Submitted on the opposite strand 101/101
(100 %)
6 diff
(94.1 %id)
AW368462 head_neck .f 156 to 711 570 to 16       555/576
(96 %)
7 diff
(98.8 %id)
CN362191 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 167 to 953 1 to 786       786/786
(100 %)
5 diff
(99.4 %id)
AA665223 alveolar rhabdomyosarcoma .f 187 to 662 1 to 476       476/478
(99 %)
2 diff
(99.6 %id)
AA923517 2 pooled tumors (clear cell type), Kidney .f 187 to 680 496 to 3       494/496
(99 %)
0 diff
(100 %id)
BU683981 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 189 to 662 577 to 104   AAA   474/559
(84 %)
0 diff
(100 %id)
BG033552 breast, mammary adenocarcinoma, cell line .f 196 to 861 28 to 696       669/1120
(59 %)
18 diff
(98.4 %id)
AI418513 pooled .f 197 to 714 524 to 8       517/524
(98 %)
1 diff
(99.9 %id)
FN163601 breast carcinoma .f 202 to 295 96 to 1     Submitted on the opposite strand 96/96
(100 %)
2 diff
(98.0 %id)
FN126893 breast carcinoma .f 210 to 302 92 to 1     Submitted on the opposite strand 92/93
(98 %)
3 diff
(96.8 %id)
AA837523 epithelium (cell line), Prostate .f 217 to 703 487 to 1       487/487
(100 %)
0 diff
(100 %id)
AI359320 brain, glioblastoma (pooled) .f 239 to 677 440 to 2       439/440
(99 %)
0 diff
(100 %id)
AI309273 2 pooled tumors (clear cell type), Kidney .f 245 to 680 438 to 3       436/438
(99 %)
0 diff
(100 %id)
FN065567 breast carcinoma .f 250 to 341 1 to 92       92/92
(100 %)
0 diff
(100 %id)
AI522278 Kidney .f 259 to 661 403 to 1       403/403
(100 %)
0 diff
(100 %id)
DN912715   .f 262 to 574 1 to 313       313/313
(100 %)
3 diff
(99.1 %id)
FN108632 breast carcinoma .f 277 to 345 82 to 13     Submitted on the opposite strand 70/83
(84 %)
0 diff
(100 %id)
AA904977 pooled .f 295 to 721 427 to 1       427/427
(100 %)
2 diff
(99.6 %id)
AA938272 2 pooled tumors (clear cell type), Kidney .f 296 to 680 387 to 3       385/387
(99 %)
0 diff
(100 %id)
BF796264 lymph, lymphoma, cell line .f 297 to 1034 1 to 734       734/950
(77 %)
8 diff
(99.2 %id)
N40939 multiple sclerosis lesions .f 315 to 713 399 to 1   fully sequenced,   399/399
(100 %)
0 diff
(100 %id)
BG199160   .f 346 to 1036 1 to 687       687/688
(99 %)
26 diff
(96.3 %id)
AA729379 alveolar rhabdomyosarcoma .f 351 to 662 322 to 11       312/422
(73 %)
0 diff
(100 %id)
AA887965 colon, colon tumor RER+ .f 382 to 672 291 to 1       291/291
(100 %)
0 diff
(100 %id)
FN048599 breast carcinoma .f 393 to 463 1 to 69       69/70
(98 %)
3 diff
(95.8 %id)
N30240 placenta .f 402 to 721 324 to 2   fully sequenced,   323/324
(99 %)
1 diff
(99.7 %id)
AI671972 pooled germ cell tumors .f 422 to 662 242 to 2       241/255
(94 %)
0 diff
(100 %id)
BG204316   .f 431 to 622 1 to 194       194/194
(100 %)
12 diff
(93.9 %id)
AI028109 parathyroid gland, parathyroid tumor .f 432 to 722 299 to 9       291/299
(97 %)
0 diff
(100 %id)
CA314511 Human Lung Epithelial cells, lung .f 433 to 870 454 to 17   AAA   438/447
(97 %)
0 diff
(100 %id)
AA094652   .f 438 to 701 1 to 258       258/258
(100 %)
8 diff
(96.9 %id)
AA883262 parathyroid gland, parathyroid tumor .f 440 to 839 412 to 13   AAA   400/400
(100 %)
1 diff
(99.8 %id)
AA887781 colon, colon tumor RER+ .f 452 to 713 290 to 29   AAA   262/262
(100 %)
0 diff
(100 %id)
AI744447 colon .f 453 to 854 403 to 1       403/403
(100 %)
2 diff
(99.6 %id)
AW592944 pooled .f 461 to 729 280 to 13   AAA   268/268
(100 %)
2 diff
(99.3 %id)
AI077790 parathyroid gland, parathyroid tumor .f 490 to 839 362 to 13   AAA   350/350
(100 %)
0 diff
(100 %id)
BG220530   .f 506 to 637 1 to 131       131/131
(100 %)
4 diff
(97.0 %id)
BG185727   .f 508 to 662 1 to 154       154/166
(92 %)
3 diff
(98.2 %id)
BG214842   .f 508 to 680 1 to 171       171/177
(96 %)
8 diff
(95.5 %id)
BG214843   .f 508 to 660 1 to 152       152/161
(94 %)
2 diff
(98.8 %id)
BG215959   .f 508 to 680 1 to 172       172/178
(96 %)
6 diff
(96.7 %id)
BG220531   .f 508 to 870 1 to 362   AAA   362/362
(100 %)
2 diff
(99.5 %id)
DA732534   .f 516 to 1282 2 to 773   capped   772/774
(99 %)
18 diff
(97.7 %id)
AW860883 colon .f 518 to 1037 1 to 520       520/524
(99 %)
3 diff
(99.5 %id)
AA627292 colon, colon tumor RER+ .f 566 to 662 97 to 1       97/97
(100 %)
3 diff
(97.0 %id)
BE698394 uterus_tumor .f 576 to 853 1 to 278       278/281
(98 %)
6 diff
(97.9 %id)
FN061820 breast carcinoma .f 600 to 667 74 to 4     Submitted on the opposite strand 71/76
(93 %)
0 diff
(100 %id)
FN122048 breast carcinoma .f 650 to 724 75 to 1     Submitted on the opposite strand 75/76
(98 %)
0 diff
(100 %id)
FN138132 breast carcinoma .f 662 to 771 108 to 1     Submitted on the opposite strand 108/117
(92 %)
3 diff
(97.5 %id)
AL517366 brain, neuroblastoma, neuroblastoma cells .f 975 to 1931 967 to 15   fully sequenced,   953/967
(98 %)
4 diff
(99.6 %id)
DB379276 placenta .f 1247 to 1838 587 to 3       585/600
(97 %)
0 diff
(100 %id)
BG698475 skin .f 1271 to 2010 28 to 761       734/761
(96 %)
6 diff
(99.3 %id)
BU633907 cell lines, Chondrosarcoma .f 1315 to 1989 690 to 19   AAA   672/676
(99 %)
6 diff
(99.2 %id)
TI_149283297   .f 1322 to 1989 786 to 120       667/786
(84 %)
0 diff
(100 %id)
TI_149310331   .f 1328 to 1981 736 to 85   AAA   652/880
(74 %)
5 diff
(99.5 %id)
BU688644 lung, Primary Lung Epithelial Cells .f 1328 to 1981 668 to 17   AAA   652/666
(97 %)
5 diff
(99.3 %id)
AI925483 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 1439 to 1989 550 to 1       550/550
(100 %)
1 diff
(99.9 %id)
AW170412 cervix, tumor .f 1455 to 1991 540 to 4       537/540
(99 %)
0 diff
(100 %id)
BE220535 malignant melanoma, metastatic to lymphnode, skin .f 1482 to 1979 498 to 1       498/498
(100 %)
0 diff
(100 %id)
AI688151 colon .f 1488 to 1990 504 to 2       503/504
(99 %)
0 diff
(100 %id)
AW062346 colon .f 1494 to 1995 513 to 12       502/513
(97 %)
0 diff
(100 %id)
AW514809 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1494 to 1982 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AA599786 bone marrow stroma .f 1500 to 1964 465 to 1       465/466
(99 %)
0 diff
(100 %id)
AI560848 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1503 to 1989 498 to 12   AAA   487/487
(100 %)
0 diff
(100 %id)
BE350848 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .f 1505 to 1989 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AA166871   .f 1518 to 2014 1 to 488       488/589
(82 %)
14 diff
(97.7 %id)
AA864875 Kidney .f 1518 to 1991 475 to 2       474/475
(99 %)
0 diff
(100 %id)
AI023075 senescent fibroblast .f 1520 to 1886 372 to 6       367/372
(98 %)
0 diff
(100 %id)
CB051760 leiomyosarcoma, soft tissue .f 1523 to 1974 515 to 62   AAA   454/463
(98 %)
15 diff
(96.8 %id)
DB568386 hypothalamus .f 1536 to 1990 1 to 455     Submitted on the opposite strand 455/461
(98 %)
1 diff
(99.8 %id)
DB568393 hypothalamus .f 1541 to 1990 1 to 450     Submitted on the opposite strand 450/456
(98 %)
1 diff
(99.8 %id)
AI807947 pooled .f 1541 to 1992 464 to 13   AAA   452/452
(100 %)
13 diff
(97.2 %id)
AW514579 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1542 to 1998 459 to 3       457/459
(99 %)
0 diff
(100 %id)
AI860340 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1546 to 1990 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI978602 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1548 to 1986 445 to 7       439/445
(98 %)
0 diff
(100 %id)
CA313983 Human Lung Epithelial cells, lung .f 1548 to 1989 458 to 17   AAA   442/451
(98 %)
0 diff
(100 %id)
CA314047 Human Lung Epithelial cells, lung .f 1548 to 1989 458 to 17   AAA   442/451
(98 %)
0 diff
(100 %id)
DB553635 hypothalamus .f 1562 to 1990 1 to 431     Submitted on the opposite strand 431/437
(98 %)
6 diff
(98.7 %id)
DB556403 hypothalamus .f 1563 to 1991 1 to 429     Submitted on the opposite strand 429/429
(100 %)
2 diff
(99.6 %id)
BG943661 blood .f 1575 to 1989 452 to 38   AAA   415/415
(100 %)
1 diff
(99.8 %id)
BG941469 blood .f 1581 to 1989 437 to 29   AAA   409/409
(100 %)
3 diff
(99.3 %id)
AI283592 pooled .f 1581 to 1990 413 to 4       410/413
(99 %)
0 diff
(100 %id)
AI374788   .f 1581 to 1990 416 to 7       410/416
(98 %)
0 diff
(100 %id)
AA683152   .f 1594 to 1990 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AA743159 germinal center B cell .f 1615 to 1990 384 to 9       376/384
(97 %)
0 diff
(100 %id)
AI379932 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1622 to 1986 368 to 4       365/368
(99 %)
0 diff
(100 %id)
BE245101 leukopheresis .f 1629 to 2138 510 to 1       510/512
(99 %)
4 diff
(99.3 %id)
BE780250 eye, retinoblastoma .f 1650 to 1981 1 to 332   AAA   332/332
(100 %)
0 diff
(100 %id)
AI333717 lung .f 1652 to 2124 475 to 3   tiling clone,   473/475
(99 %)
0 diff
(100 %id)
AI432056 adenocarcinoma, Pancreas .f 1672 to 1990 322 to 4       319/322
(99 %)
0 diff
(100 %id)
AI128904 senescent fibroblast .f 1684 to 1989 318 to 13   AAA   306/306
(100 %)
0 diff
(100 %id)
BM150962 leukopheresis .f 1684 to 2147 469 to 8       462/470
(98 %)
0 diff
(100 %id)
AV744564 cord Blood .f 1701 to 1981 20 to 290   AAA   271/290
(93 %)
6 diff
(98.0 %id)
BQ024262 placenta .f 1707 to 1992 304 to 19   AAA   286/286
(100 %)
2 diff
(99.4 %id)
BM144936 leukopheresis .f 1739 to 1974 256 to 21   AAA   236/236
(100 %)
4 diff
(98.4 %id)
AA890688 parathyroid gland, parathyroid tumor .f 1746 to 1868 125 to 1       125/125
(100 %)
2 diff
(98.4 %id)
AW150433 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1754 to 1991 240 to 2       239/240
(99 %)
0 diff
(100 %id)
FN165496 breast carcinoma .f 1769 to 1886 1 to 120       120/121
(99 %)
5 diff
(95.9 %id)
TI_149279748   .f 1787 to 2523 847 to 118   tiling clone,   730/1235
(59 %)
0 diff
(100 %id)
FN147949 breast carcinoma .f 1800 to 1916 1 to 114       114/120
(95 %)
4 diff
(96.7 %id)
N38909.
matches multiple genes
melanocyte .f 1817 to 1989 174 to 1     also hits gene EXTL3 174/174
(100 %)
1 diff
(99.5 %id)
AA905402 pooled .f 1843 to 1991 153 to 5       149/153
(97 %)
0 diff
(100 %id)
AA865015 germinal center B cell .f 1854 to 1995 163 to 22   AAA   142/142
(100 %)
0 diff
(100 %id)
FN144891 breast carcinoma .f 1855 to 1917 69 to 8     Submitted on the opposite strand 62/69
(89 %)
0 diff
(100 %id)
EC496227 Prostate .f 1877 to 1991 1 to 115       115/117
(98 %)
5 diff
(95.8 %id)
FN149217 breast carcinoma .f 1926 to 1979 1 to 54       54/55
(98 %)
1 diff
(98.2 %id)
AA211198   .f 2036 to 2350 1 to 314       314/319
(98 %)
6 diff
(98.2 %id)
AA211216   .f 2036 to 2356 1 to 319   tiling clone,   319/319
(100 %)
3 diff
(99.1 %id)
H54509 liver and spleen .f 2349 to 2599 1 to 251   tiling clone,   251/251
(100 %)
1 diff
(99.7 %id)
BF911425 uterus_tumor .f 2383 to 2713 373 to 43   tiling clone, Submitted on the opposite strand 331/385
(85 %)
0 diff
(100 %id)
DB367821   .f 2545 to 3103 559 to 1       559/559
(100 %)
11 diff
(98.1 %id)
DB364067   .f 2557 to 3103 545 to 1       545/547
(99 %)
12 diff
(97.9 %id)
BF431502 Kidney .f 2648 to 3105 457 to 1   tiling clone,   457/457
(100 %)
1 diff
(99.8 %id)
AA211087   .f 2704 to 3106 406 to 1       406/408
(99 %)
3 diff
(99.3 %id)
AI469129 colon, moderately-differentiated adenocarcinoma .f 2707 to 3100 402 to 11   AAA   392/392
(100 %)
3 diff
(99.3 %id)
AA211111   .f 2708 to 3106 403 to 2       402/407
(98 %)
0 diff
(100 %id)
DA727579   .f 2713 to 3345 2 to 636   tiling clone, capped   635/654
(97 %)
7 diff
(99.0 %id)
H54419 liver and spleen .f 2906 to 3175 272 to 1       272/273
(99 %)
4 diff
(98.6 %id)
AV755683 bone marrow .g 1 to 652 123 to 774 P136S tiling clone, AAA   658/668
(98 %)
9 diff
(98.7 %id)
BM471081 melanotic melanoma, skin .g 66 to 1030 1 to 963 exact tiling clone,   963/981
(98 %)
17 diff
(98.3 %id)
CN362193 embryonic stem cells, cell lines H1, H7, andH9 .h 1 to 693 1 to 694 exact tiling clone,   694/694
(100 %)
2 diff
(99.8 %id)
DA820769 pericardium .i 1 to 561 7 to 567 exact tiling clone, capped   566/567
(99 %)
1 diff
(99.9 %id)
BM840067 lymph node, stomach .j 1 to 560 6 to 565 exact tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
BM841054 lymph node, stomach .j 1 to 489 6 to 494 exact     494/494
(100 %)
0 diff
(100 %id)
BM846472 lymph node, stomach .j 1 to 547 6 to 552 exact     552/552
(100 %)
2 diff
(99.7 %id)
BM760040 lymph node, stomach .j 1 to 528 5 to 531 exact     531/531
(100 %)
3 diff
(99.5 %id)
BM838654 lymph node, stomach .j 1 to 527 5 to 531 exact     531/531
(100 %)
2 diff
(99.7 %id)
BX479720   .j 33 to 377 49 to 393 Y63D     393/393
(100 %)
6 diff
(98.5 %id)
CF597376 ovary .k -8 to 365 1 to 377 N51Y     377/865
(43 %)
9 diff
(99.0 %id)
DB195199 trachea .k 1 to 446 10 to 456 exact tiling clone, capped   455/455
(100 %)
1 diff
(99.8 %id)
CR749344 Liver .k 1 to 2100 6 to 2105 L25S tiling clone, available from DKFZ, AAA   2105/2105
(100 %)
7 diff
(99.7 %id)
BM473311 duodenal adenocarcinoma, cell line, small intestine .k 281 to 1194 1 to 924   tiling clone,   924/1097
(84 %)
23 diff
(98.0 %id)
BG943201 blood .l-u 1 to 279 332 to 55   tiling clone, AAA   278/301
(92 %)
0 diff
(100 %id)
BM721790 eye, fetal eye .l-u 254 to 676 26 to 453   tiling clone,   428/453
(94 %)
6 diff
(98.7 %id)
AW864410 stomach_normal .l-u 629 to 1143 13 to 528   tiling clone,   516/528
(97 %)
6 diff
(98.9 %id)
BM677367 eye, fetal eye .l-u 1052 to 1497 527 to 82   tiling clone, AAA   446/509
(87 %)
0 diff
(100 %id)
BG676547 skin, squamous cell carcinoma .m 1 to 489 373 to 855 Y28S I29H L30F Q31T     483/857
(56 %)
21 diff
(97.6 %id)
BG776654 lung, mucoepidermoid carcinoma .m 1 to 655 24 to 680 exact tiling clone,   657/683
(96 %)
20 diff
(97.1 %id)
BM142386 Islets of Langerhans, Pancreas .m 1 to 417 148 to 564 exact     417/564
(73 %)
9 diff
(98.5 %id)
BX382682 Placenta Cot 25-normalized .m 9 to 973 965 to 1 Y4X L30*     965/965
(100 %)
12 diff
(98.8 %id)
TI_149273247   .m 58 to 852 887 to 103 W2T F3I Y4X Y5* tiling clone, AAA   785/785
(100 %)
31 diff
(96.1 %id)
ES316250 pool of melanoma cell lines .m 128 to 581 85 to 538 exact     454/538
(84 %)
14 diff
(97.4 %id)
BM142561 Islets of Langerhans, Pancreas .m 435 to 1007 573 to 1   tiling clone,   573/573
(100 %)
0 diff
(100 %id)
BF575567 muscle (skeletal) .n 1 to 729 7 to 728 L25C L26Y R27V G28D C29V ... tiling clone,   728/861
(84 %)
33 diff
(96.2 %id)
CN277601 embryonic stem cells, DMSO-treated H9 cellline Gene MRPL42, variant not shown         This clone was ignored    
BX387873   Gene MRPL42, variant not shown         This clone was ignored    
BX387874   Gene MRPL42, variant not shown         This clone was ignored    
AV712590   Gene MRPL42, variant not shown         This clone was ignored    
AV715977   Gene MRPL42, variant not shown         This clone was ignored    
AV716587   Gene MRPL42, variant not shown         This clone was ignored    
AV716758   Gene MRPL42, variant not shown         This clone was ignored    
AV714046   Gene MRPL42, variant not shown         This clone was ignored    
BP263118 small intestine Gene MRPL42, variant not shown         Suspected internal deletion, this clone was ignored    
DA754660   Gene MRPL42, variant not shown       capped This clone was ignored    
BM728318 eye, fetal eye Gene MRPL42, variant not shown         This clone was ignored    
BU742854 eye, fetal eye Gene MRPL42, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI